Feeds:
Posts
Comments

Search Results for 'double edged'

Diagnostic and Interventional Cardiology (DAIC): 2020 Top 25 Best Performing Articles Reporter: Aviva Lev-Ari, PhD, RN   Here are the top 25 best performing articles on the Diagnostic and Interventional Cardiology (DAIC) website from 2020. This is based on the analytics of DAIC’s record 3.3 million pages views in 2020: 1. Kawasaki-like Inflammatory Disease Affects Children […]

Read Full Post »

View on Amazon.com http://www.amazon.com/dp/B0BR8GYBG7   Audio y Texto NEW GENRE Volume Three:  The Immune System and Therapeutics https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-d-e-books-on-biomedicine-metabolomics-immunology-infectious-diseases-reproductive-genomic-endocrinology/new-genre-volume-three-the-immune-system-and-therapeutics-pharmaceutics-series-d-volume-3-%ef%bf%bc/   Original Volume Three in the Volume Two and Three combined format: The Immune System and Therapeutics Original Volume Two & Three were published as ONE volume:  The Immune System, Stress Signaling, Infectious Diseases and Therapeutic Implications VOLUME 2: Infectious […]

Read Full Post »

  View on Amazon.com https://www.amazon.com/dp/B0BQTM44SM Audio y Texto NEW GENRE Volume Two: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery  https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-c-e-books-on-cancer-oncology/new-genre-volume-two-cancer-therapies-metabolic-genomics-interventional-immunotherapy-and-nanotechnology-in-therapy-delivery-series-b-volume-2%ef%bf%bc/   Original Volume 2: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery (Series C Book 2).   On com since 5/18/2017 http://www.amazon.com/dp/B071VQ6YYK   NEW GENRE Volume Two: Cancer Therapies: Metabolic, Genomics, Interventional, […]

Read Full Post »

SAR-Cov-2 is probably a vasculotropic RNA virus affecting the blood vessels: Endothelial cell infection and endotheliitis in COVID-19 Reporter: Aviva Lev-Ari, PhD, RN – Bold face and colors are my addition From: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Reply-To: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Date: Tuesday, June 2, 2020 at 8:50 AM To: Aviva Lev-Ari <aviva.lev-ari@comcast.net> Subject: Re: […]

Read Full Post »

Voices of Global Citizens: Impact of The Coronavirus Pandemic Gail S. Thornton, M.A.  Lead Curator – e–mail Contact:  gailsthornton@yahoo.com    Voices of Patients Tested Positive to Coronavirus Infections in the US Voices of Nurses and Allied Health Care Professionals in the US in the Coronavirus Pandemic Voices of Physicians at Hospitals Caring for Coronavirus Pandemic Voices of Americans during […]

Read Full Post »

1/17/2021 Five Countries, Five Experiences of the Pandemic Citizens from around the world share their coronavirus stories. Reporter: Gail S. Thornton, M.A. By Dhruv KhullarJanuary 17, 2021 SOURCE: https://www.newyorker.com/science/medical-dispatch/five-countries-five-experiences-of-the-pandemic?utm_source=nl ### 11/17/2020 Multi-dimensional factors driving the pandemic and how their impact decides any return to the pre- COVID-19 world! Reporter: Gail S. Thornton, M.A. Published on October […]

Read Full Post »

Tumor Associated Macrophages: The Double-Edged Sword Resolved? Writer/Curator: Stephen J. Williams, Ph.D. UPDATED 10/04/2021 TAMs Enhance Tumor Hypoxia and Aerobic Glycolysis Cell-based immunity is vital for our defense against pathologic insult but recent evidence has shown the role of cell-based immunity, especially macrophages to play an important role in both the development and hindrance of […]

Read Full Post »

Immune System Stimulants: Articles of Note @pharmaceuticalintelligence.com Curators: Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN   New Approaches to Immunotherapy   New Class of Immune System Stimulants: Cyclic Di-Nucleotides (CDN): Shrink Tumors and bolster Vaccines, re-arm the Immune System’s Natural Killer Cells, which attack Cancer Cells and Virus-infected Cells Three Methods for […]

Read Full Post »

Oncolytic Virotherapy for Pancreatic Cancer: Overcoming Obstacles in Oncolytic Virus Delivery Reporter: Aviva Lev-Ari, PhD, RN   We covered MGH’s Innovation on Tumor targeted therapy in Pancreatic Cancer in Pancreatic Cancer Targeted Treatment? Curator: Larry H. Bernstein, MD, FCAP https://pharmaceuticalintelligence.com/2016/05/18/pancreatic-cancer-targeted-treatment/   Below, we report on the State of the Science for Overcoming Obstacles in Oncolytic Virus […]

Read Full Post »

Are CXCR4 Antagonists Making a Comeback in Cancer Chemotherapy? Reporter: Stephen J. Williams, Ph.D. Biospace News reported that Massachusetts based X4 Pharmaceuticals is using $34B to launch two clinical trials on its CXCR4 inhibitor X4P-001 in refractory clear cell renal cell carcinoma and refractory epithelial ovarian cancer. The full report is below: X4 Pharma Uses […]

Read Full Post »

Next »